Quidel

Yahoo Finance • last month

Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake?

Key Points New York City-based Newtyn Management sold 807,135 shares of Millrose Properties, reducing its position by $23 million in the third quarter. The transaction represented approximately 2.8% of reported 13F assets under management... Full story

Yahoo Finance • last month

Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock

Key Points New York City-based Newtyn Management added 1.35 million shares of Array Digital Infrastructure, an estimated $67.5 million trade based on quarterly average pricing. The position change represents 8.3% of 13F reportable assets... Full story

Yahoo Finance • last month

Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge

Key Points New York City-based Newtyn Management increased its stake in Indivior by nearly 1.6 million shares in the third quarter, resulting in a net position change of $62.8 million. The transaction represents a nearly 4.1% change in 13... Full story

Yahoo Finance • 2 months ago

BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government financial aids to help p... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves midday: Oracle, Bath & Body Works, Gap and more

Check out the companies making the biggest moves midday: Oracle — The AI stock fell 4% as investors remained worried about valuations tied to AI continued to dump stocks. Those declines added to Oracle's and Nvidia's steep weekly losses. B... Full story

Yahoo Finance • 2 months ago

QuidelOrtho narrows 2025 revenue guidance to $2.68B–$2.74B as margin initiatives deliver $140M in cost savings

Earnings Call Insights: QuidelOrtho Corporation (QDEL) Q3 2025 MANAGEMENT VIEW * CEO Brian Blaser highlighted "another solid performance that reflects the strength of our diversified global diagnostics portfolio," reporting organic sal... Full story

Yahoo Finance • 2 months ago

QuidelOrtho Corporation Q3 25 Earnings Conference Call At 5:00 PM ET

(RTTNews) - QuidelOrtho Corporation (QDEL) will host a conference call at 5:00 PM ET on November 5, 2025, to discuss Q3 25 earnings results. To access the live webcast, log on to https://ir.quidelortho.com/events-and-presentations/default... Full story

Yahoo Finance • 3 months ago

UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 4 months ago

QuidelOrtho Corp. (QDEL) Traded Lower Due to Macro Concerns

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S. equity market showcased a significant recovery during the qua... Full story

Yahoo Finance • 4 months ago

Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters

SAN DIEGO, Sept. 25, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released the latest episode of its Science Bytes podcast, featuring Dr. Terry O'Neil, President and Medical Dire... Full story

Yahoo Finance • 4 months ago

QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In QuidelOrtho (QDEL) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in QuidelOrtho between Februa... Full story

Yahoo Finance • 5 months ago

QuidelOrtho names Erich Wolff as EVP of strategy & corporate development

SAN DIEGO - QuidelOrtho Corporation (NASDAQ:QDEL), a provider of in vitro diagnostics, has appointed Erich Wolff as Executive Vice President, Strategy & Corporate Development, the company announced Tuesday. In his new role, Wolff will rep... Full story

Yahoo Finance • 5 months ago

Quidel stock price target lowered to $55 by Raymond James on prudent guidance

Investing.com - Raymond James has lowered its price target on Quidel Corp . (NASDAQ:QDEL) to $55.00 from $60.00 while maintaining an Outperform rating on the stock. The new target represents significant upside potential from the current p... Full story

Yahoo Finance • 5 months ago

QuidelOrtho narrows China outlook to mid-single-digit growth as cost actions drive margin gains

Earnings Call Insights: QuidelOrtho Corporation (QDEL) Q2 2025 MANAGEMENT VIEW * CEO Brian J. Blaser reported that "total revenue of $614 million grew 1%, excluding COVID and the Donor Screening business, which we are in the process of... Full story

Yahoo Finance • 5 months ago

QuidelOrtho Reports Second Quarter 2025 Financial Results

― Labs revenue grew 4% as reported and 5% in constant currency ― ― Adjusted EBITDA margin improved by 330 basis points; Achieved $100 million annualized cost savings from initiatives announced in 2024 ― ― Company reiterates full-year 2025... Full story

Yahoo Finance • 5 months ago

QuidelOrtho Corporation (QDEL): A Bull Case Theory

We came across a bullish thesis on QuidelOrtho Corporation on Valueinvestorsclub.com by Novana. In this article, we will summarize the bulls’ thesis on QDEL. QuidelOrtho Corporation's share was trading at $27.39 as of July 25th. QDEL’s tra... Full story

Yahoo Finance • 5 months ago

Quidel stock hits 52-week low at $23.75

Quidel (NASDAQ:QDEL) Corporation’s stock reached a 52-week low, closing at $23.75, with a market capitalization of $1.6 billion. This marks a significant downturn for the company, which has experienced a 42.83% decrease in its stock value... Full story

Yahoo Finance • 5 months ago

PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending shockwaves across the health... Full story

Yahoo Finance • 6 months ago

Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story

Yahoo Finance • 6 months ago

QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

New executives bring deep expertise to elevate quality and accelerate innovation across global operations SAN DIEGO, July 7, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider o... Full story